摘要
目的:探讨复方玄驹胶囊联合万艾可治疗万艾可渐进性失效勃起功能障碍(ED)的临床疗效。方法:将符合万艾可渐进性失效ED诊断标准的36例患者随机分成两组,每组各18例。其中治疗组给予复方玄驹胶囊(口服,2粒/次,3次/日)和万艾可50 mg(性生活前1 h口服)口服;对照组单纯口服万艾可100 mg(性生活前1 h口服)。两组性生活频率1~2次/周,观察期2个月,对用药前后患者国际勃起功能评分(IIEF-5)及TSS伴侣评分进行对比分析。结果:两组每次使用万艾可对勃起功能改善的有效率比较,治疗组总有效率94.44%,对照组88.89%,两组对比差异无显著性意义(P>0.05)。IIEF-5评分治疗组治疗前后分别为(13.166 7±3.601 5)和(20.888 9±3.833 1),而对照组治疗前后分别为(13.055 6±2775 4)和(18.777 8±4.008 2),每组治疗前后对比差异有显著性意义(P<0.05);治疗后两组IIEF-5评分及TSS伴侣评分比较,治疗组的效果均比对照组好,且差异具有显著性意义(P<0.05)。结论:复方玄驹胶囊联合万艾可治疗万艾可渐进性失效ED疗效显著。
Objective: To explore the clinical effects of Compound Xuanju Capsule (CXC) combined with sildenafil on erectile dysfunction (ED) that progressively fails to respond to sildenafil. Methods: Totally, 36 ED patients who progressively failed to re- spond to sildenafil were randomly divided into a trial and a control group of equal number, the former treated with oral CXC at 3 g tid plus sildenafil at 50 mg an hour before sexual activity, while the latter with sildenafil alone at 100 mg an hour before sexual activity. After 2 months of treatment, we compared the patients scores on IIEF-5 and their partners scores on Treatment Satisfaction Scale (TSS) between the two groups. Results : The total rate of erectile function improvement was 94.44% in the trial and 88.89% in the control group (P 〉0.05). The IIEF-5 score was 20. 888 9±3. 833 1 in the former and 18. 777 8±4. 008 2 in the latter after treat- ment, significantly higher than 13. 166 7 ±3. 601 5 and 13. 055 6± 2. 775 4 before treatment (P 〈0.05). The post-treatment IIEF-5 scores of the patients and the TSS scores of their partners were markedly higher in the trial than in the control group (P 〈 0. 05 ). Conclusion: Compound Xuanju Capsule combined with sildenafil is effective for erectile dysfunction that progressively fails to respond to sildenafil.
出处
《中华男科学杂志》
CAS
CSCD
2012年第12期1101-1104,共4页
National Journal of Andrology
关键词
复方玄驹胶囊
万艾可
勃起功能障碍
Compound Xuanju Capsule
sildenafil
erectile dysfunction